WHO
REGULATORY UPDATE
Hetero’s Darunavir (ethanolate)/Ritonavir, FDC tablets prequalified
Published: 8/18/2026Detected: 6/17/2026
Summary preview
Adds Hetero’s WHO Prequalification list entries for fixed-dose combination (FDC) darunavir (ethanolate)/ritonavir tablets at 400mg/50mg and 800mg/100mg strengths.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountOfficial Source Document Source Verified
Access the original document directly from WHO.